Best online clinics for Lexapro

Looking for mental health care without the wait? Here’s what you need to know about the best—and worst—online options available today.

Mental health care has gone digital. In 2026, millions of Americans turn to telehealth platforms for everything from anxiety treatment to ADHD medication management. But not all services are created equal—and some have spectacularly failed their patients.

If you’re considering online mental health care, you’re probably asking: Which platforms actually work? Which prescribe the medications I need? And which ones can I trust?

This comprehensive guide breaks down the current telehealth landscape, comparing major providers on what matters most: availability, prescribing policies, cost, and quality of care. We’ll also explore why some once-popular services have shut down or scaled back—and what that means for your treatment options.

The 2026 Telehealth Mental Health Landscape: What’s Changed

The online mental health industry looks vastly different today than it did just three years ago. The pandemic-era boom gave way to a sobering reality check, with regulatory scrutiny, business failures, and patient safety concerns reshaping the market.

Major Players Still Standing

As of early 2026, several established platforms continue to serve patients nationwide:

• Full-service psychiatric care: Talkiatry offers comprehensive psychiatry with licensed MDs who can prescribe any appropriate medication, including controlled substances when clinically warranted
• Depression and anxiety specialists: Brightside focuses exclusively on mood disorders, using non-controlled medications and therapy
• General telehealth with mental health: Teladoc, MDLive, and Amwell provide psychiatric consultations alongside urgent care and primary medicine
• Primary care platforms: PlushCare offers mental health treatment as part of broader medical services
• Lifestyle-focused services: Hims & Hers expanded from men’s wellness into anxiety, depression, and weight management

Notable Exits and Casualties

The industry has seen significant attrition:

Done Global effectively ceased operations after federal prosecutors indicted its CEO and president in June 2024 for allegedly running what authorities called a ‘pill mill’ that distributed millions of Adderall prescriptions without legitimate medical purpose. The criminal case—the first of its kind against telehealth executives—sent shockwaves through the industry.

Ahead (HelloAhead) shut down in mid-2022 amid financial difficulties and operational challenges, leaving thousands of ADHD patients scrambling for alternative care.

Cerebral survived but dramatically changed its business model. After facing intense scrutiny for aggressive ADHD medication prescribing practices, the company stopped initiating new stimulant prescriptions in May 2022 and paid $3.6 million in settlement fees in 2024. Today, Cerebral operates with significantly tighter prescribing protocols.

These failures weren’t just business stories—they disrupted care for hundreds of thousands of patients and raised fundamental questions about telehealth safety standards.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

Side-by-Side Comparison: Top Mental Health Telehealth Platforms

Understanding your options requires looking at what each platform actually offers—and what it doesn’t. The table below compares operating status, conditions treated, medication capabilities, availability, pricing, and insurance acceptance across major providers.

Key Insights from This Comparison

Only specialized psychiatric services prescribe controlled medications. If you need ADHD stimulants or medications for severe anxiety, your options have narrowed considerably. Talkiatry remains the primary telehealth option for controlled substance prescriptions, operating through traditional insurance-based psychiatry.

General telehealth platforms have strict limits. Despite treating mental health conditions, services like Teladoc, MDLive, and PlushCare categorically refuse to prescribe Schedule II stimulants or benzodiazepines via telehealth. These policies reflect risk management and regulatory caution, not clinical inability.

Subscription models dominate but vary widely. Most mental health-specific platforms use monthly fees ranging from $85 to $365, while general telehealth typically charges per visit. This pricing structure can become expensive if you need ongoing care but don’t require weekly appointments.

Understanding Medication Prescribing Policies: What You Can (and Can’t) Get Online

Medication access represents the most significant differentiator among telehealth mental health services. Recent regulatory pressure and legal cases have created a conservative prescribing environment, especially for controlled substances.

ADHD Stimulants (Schedule II): Severely Restricted

Current Reality: Very few telehealth platforms prescribe Adderall, Ritalin, or similar Schedule II stimulants as of 2026.

Talkiatry represents the primary telehealth option, operating as a traditional psychiatric practice that happens to conduct visits virtually. Their board-certified psychiatrists can prescribe stimulants when clinically appropriate, following the same evaluation standards as in-person care.

What changed? The dramatic shift followed the Done Global indictment and Cerebral’s settlement. Done executives allegedly prescribed over 40 million pills of Adderall and similar stimulants through 30-minute video appointments with minimal evaluation. Federal prosecutors called it ‘drug dealing with a laptop.’

Cerebral, which once marketed heavily to ADHD patients, stopped all new stimulant prescriptions in May 2022 after the DEA launched an investigation into its practices. Existing patients could continue their medications through 2023, but the company fundamentally pivoted away from stimulant-focused care.

General telehealth platforms—Teladoc, MDLive, PlushCare, Amwell—never prescribed ADHD stimulants via telehealth, citing regulatory uncertainty and liability concerns. These policies remain unchanged in 2026.

What this means for patients: If you need ADHD medication management, you’ll likely need either:

• Insurance-based telepsychiatry (like Talkiatry)
• Traditional in-person psychiatric care
• Hybrid models that combine some telehealth with required in-person visits

Anti-Anxiety Benzodiazepines (Schedule IV): Almost Universally Excluded

Platforms have adopted similarly restrictive policies for benzodiazepines like Xanax (alprazolam), Ativan (lorazepam), and Klonopin (clonazepam).

Brightside’s policy explicitly states: ‘Brightside does not prescribe controlled substances, including medications such as Xanax or Ativan.’ This reflects concern about dependence risks and regulatory scrutiny.

Cerebral similarly avoids benzodiazepines entirely, instead offering SSRIs, SNRIs, and other non-controlled anxiety medications.

PlushCare, Teladoc, and MDLive all prohibit benzodiazepine prescriptions in their telehealth policies.

Only full psychiatric services like Talkiatry may prescribe benzodiazepines when clinically warranted—typically for patients with established treatment relationships or severe panic disorder where alternatives have failed.

Alternatives platforms do offer: Most services readily prescribe non-controlled anxiety medications including:

• SSRIs (Zoloft, Lexapro, Prozac)
• SNRIs (Effexor, Cymbalta)
• Buspirone (BuSpar)
• Hydroxyzine (Vistaril)
• Beta-blockers for performance anxiety

Sleep Medications (Schedule IV): Widely Restricted

The ‘Z-drugs’—Ambien (zolpidem), Lunesta (eszopiclone), and Sonata (zaleplon)—face similar restrictions to benzodiazepines.

Brightside’s policy specifically excludes these controlled sleep aids. Teladoc and Amwell likewise won’t prescribe them via telehealth.

Platforms instead recommend:

• Trazodone (antidepressant with sedating effects)
• Doxepin (tricyclic antidepressant for insomnia)
• Cognitive behavioral therapy for insomnia (CBT-I)
• Sleep hygiene coaching
• Melatonin or other supplements

For patients with serious insomnia requiring controlled medications, Talkiatry or in-person psychiatry remains necessary.

Weight Loss Medications: The New Frontier

While mental health platforms restrict traditional controlled substances, several have embraced GLP-1 agonist prescribing for weight management—a dramatic shift in telehealth’s scope.

Hims & Hers launched a comprehensive weight loss program in 2023, prescribing semaglutide (Wegovy/Ozempic) via telehealth. The program combines medication with nutritional coaching. Hims stock surged over 50% in 2024-2025 partly due to this service expansion.

PlushCare prescribes GLP-1s for obesity and related metabolic conditions on a case-by-case basis, treating them as standard (non-controlled) medications.

Teladoc explicitly excludes GLP-1 weight loss prescriptions from its general care offerings, though some affiliated specialists may provide them.

FDA scrutiny intensified in 2025 when regulators warned several telehealth companies about marketing compounded semaglutide versions without proper approval. Hims received such a warning but argued compounded versions are legal during shortages of brand-name drugs.

What this means: Weight loss medication access via telehealth is growing but inconsistent. If this interests you, dedicated weight management platforms or services like Hims offer more comprehensive support than general mental health telehealth.

The Regulatory Landscape: Why Policies Keep Tightening

Understanding why telehealth mental health prescribing has become so restricted requires examining the regulatory framework that governs it.

The Ryan Haight Act and COVID Flexibilities

The Ryan Haight Act (2008) normally requires an in-person medical evaluation before prescribing controlled substances. During COVID-19, federal authorities issued emergency waivers allowing tele-prescribing of controlled medications without prior in-person visits.

These waivers have been extended repeatedly—most recently through December 31, 2025. But the future beyond 2025 remains uncertain, creating business risk for telehealth companies. The DEA proposed requiring in-person visits for controlled substance prescriptions in 2023, generating fierce opposition from patient advocates and providers.

Many platforms decided not to gamble on regulatory changes. By avoiding controlled substances entirely, they eliminate compliance risk regardless of how regulations evolve.

High-Profile Enforcement Actions

The Done Global indictment marked a watershed moment. Federal prosecutors alleged that Done’s business model prioritized subscriptions over medical judgment, with internal metrics tracking ‘conversion rates’ from evaluation to prescription rather than patient outcomes.

According to charging documents, Done prescribed over $100 million worth of stimulants to patients across 50 states, many after cursory video appointments. Some patients allegedly received medications despite telling providers they planned to misuse them or share with others.

Cerebral’s settlement similarly alleged the company created internal pressure to prescribe, including compensation structures that rewarded high prescription volumes. The company agreed to compliance monitoring and policy changes.

These cases sent a clear message: aggressive tele-prescribing of controlled substances will face scrutiny.

State-Level Variations

While most platforms operate nationwide, state laws create variations:

• Some states require in-person exams for any prescription (controlled or not)
• Others have specific ADHD medication restrictions
• A few mandate ongoing in-person follow-ups for controlled substances

This patchwork means providers often adopt the most conservative national policy rather than navigate state-by-state differences.

Cost Comparison: What You’ll Actually Pay

Understanding real costs requires looking beyond advertised prices to account for insurance, subscriptions, and ongoing treatment needs.

Subscription-Based Mental Health Platforms

Brightside:

• Medication management only: $95/month
• Therapy + medication: $349/month
• Insurance may cover portions, reducing out-of-pocket costs
• Annual cost without insurance: $1,140–$4,188

Cerebral:

• Medication management: $99/month (first month; can vary)
• Therapy + medication: $365/month
• Limited insurance acceptance
• Annual cost: approximately $1,200–$4,380

Hims & Hers (Mental Health):

• Anxiety/depression medication: $85/month
• Therapy sessions: $99/session (separate)
• No insurance; cash only but HSA/FSA eligible
• Annual medication cost: $1,020

Pros of subscriptions: Predictable monthly costs; unlimited messaging with providers (on some platforms); convenient refills

Cons: You pay even months you don’t need appointments; cancellation can be difficult; costs accumulate quickly if you need therapy and medication management

Insurance-Based Psychiatric Services

Talkiatry:

• Operates as in-network psychiatry for most major insurers
• Copays typically $25–$75 per visit (varies by plan)
• Initial evaluation may cost $200–$300 out-of-pocket
• Follow-ups usually $100–$150 without insurance
• Annual cost with insurance: $300–$900 (monthly follow-ups)
• Annual cost without insurance: $1,800–$3,600+

Pros: Insurance coverage significantly reduces costs; full psychiatric care including controlled medications; legitimate medical records

Cons: Subject to insurance networks and referral requirements; may face wait times; less flexibility than cash-pay services

General Telehealth (Pay-Per-Visit)

PlushCare:

• Membership: $19.99/month
• Per visit: $129
• Insurance accepted (may reduce to copay)
• Annual cost (monthly visits): ~$240 + $1,548 = $1,788 without insurance

Teladoc/MDLive/Amwell:

• Often included free with employer or insurance plans
• Out-of-pocket: $75–$95 per general visit
• Psychiatry: $200+ per visit
• Highly variable based on insurance

Pros: Pay only when you need care; good for occasional consultations; widely covered by insurance

Cons: Mental health offerings limited; won’t prescribe controlled substances; less continuity of care

Klarity Health’s Competitive Positioning

Klarity Health offers transparent, competitive pricing that often undercuts subscription models:

• Initial evaluation: $149
• Follow-up visits: $59
• Medication refills: $25

Annual cost example (monthly medication management):

• Initial: $149
• 11 follow-ups: $649
• Total: $798

This represents 30–50% savings compared to subscription platforms like Brightside ($1,140+) or Cerebral ($1,200+) for patients who need ongoing medication management but not weekly therapy.

Klarity also accepts both insurance and cash payment, providing flexibility that pure cash-pay services like Hims lack. For patients with high-deductible plans or limited mental health coverage, Klarity’s transparent pricing eliminates surprise bills while remaining more affordable than out-of-network costs elsewhere.

What Patients Actually Say: Real-World Reviews and Complaints

Online reviews reveal consistent patterns in patient experiences across platforms.

Common Brightside Complaints

‘Doesn’t treat ADHD’ – Multiple reviewers express frustration discovering after signup that Brightside won’t diagnose or treat ADHD, despite marketing to people with focus and productivity concerns.

‘Conservative prescribing’ – Some patients appreciate the non-addictive approach; others feel their needs aren’t adequately addressed when anxiety remains severe on non-controlled medications.

‘Good for mild-moderate depression’ – Generally positive reviews for straightforward depression/anxiety treatment with SSRIs.

Cerebral’s Troubled Reputation

‘Provider turnover’ – Frequent complaints about assigned therapists or prescribers changing without notice, disrupting continuity.

‘Cut off medications abruptly’ – Some 2022-2023 reviews describe ADHD patients suddenly losing stimulant access after policy changes, with minimal transition support.

‘Difficult to cancel’ – Multiple reports of subscription cancellation problems and continued billing.

‘Mixed customer service’ – Response times and helpfulness vary dramatically in reviews.

Cerebral’s 2022 controversy significantly damaged its reputation. While the company continues operating and has implemented compliance improvements, patient trust remains lower than competitors.

Done’s Catastrophic Failure

Before its 2024 shutdown, Done reviews painted a troubling picture:

‘Too easy to get Adderall’ – Some reviewers admitted receiving prescriptions after 15-minute appointments with minimal questions, raising red flags about legitimacy.

‘Pharmacy problems’ – As scrutiny increased, many pharmacies refused to fill Done prescriptions, leaving patients in limbo.

‘Poor follow-up care’ – Complaints about difficulty reaching prescribers between monthly subscription appointments.

‘Abrupt service disruptions’ – When federal action came, patients lost access immediately with little guidance on transitioning care.

The Done case illustrates the risks of prioritizing convenience over clinical rigor.

Talkiatry’s Generally Positive Reception

‘Real psychiatrists’ – Patients appreciate seeing board-certified MDs rather than nurse practitioners or physician assistants (though all three can provide excellent care).

‘Insurance makes it affordable’ – In-network coverage significantly reduces cost barriers for many.

‘Some wait times’ – As demand grew, initial appointment availability decreased in some states (1-3 weeks typical in 2025).

‘Occasional provider changes’ – Insurance-based models sometimes require switching providers when networks change.

What This Means for Klarity

Patient feedback reveals clear expectations:

1. Consistency matters – Keep patients with the same provider when possible
2. Transparent policies upfront – Clearly state what conditions you treat and don’t treat before signup
3. Responsive support – Fast, helpful customer service differentiates platforms
4. Legitimate clinical care – Patients want thorough evaluations, not rubber-stamp prescribing
5. Reasonable access – Balance quick availability with proper assessment

Klarity can excel by learning from competitors’ pain points: offering specialized care (including conditions others won’t treat), maintaining provider continuity, providing responsive support, and keeping pricing transparent and affordable.

The Future of Mental Health Telehealth: Trends Shaping 2026 and Beyond

Several developments will reshape the industry in coming years.

Regulatory Resolution (Probably)

The Ryan Haight waiver uncertainty will likely resolve in 2026 through either:

• Permanent telehealth flexibility for controlled substances with safeguards
• Hybrid requirements (e.g., annual in-person visits plus telehealth)
• Return to strict in-person requirements (unlikely given political pressure)

Most analysts expect some middle ground—allowing telehealth prescribing but with enhanced verification, periodic in-person checks, or state medical board oversight.

Integration with Traditional Healthcare

Standalone telehealth mental health services increasingly partner with or integrate into larger healthcare systems:

• Insurance companies launching their own telepsychiatry networks
• Primary care groups adding mental health telehealth
• Hospital systems offering hybrid in-person/virtual psychiatric care

This trend offers patients better care coordination but may reduce the convenience and accessibility that made independent telehealth platforms attractive.

Specialization and Niche Focus

Rather than trying to treat everything, successful platforms increasingly specialize:

• PTSD and trauma-focused services (some incorporating ketamine-assisted therapy)
• Perinatal mental health for pregnancy and postpartum
• ADHD specialists willing to navigate controlled substance regulations responsibly
• Treatment-resistant depression programs with novel interventions

Klarity’s focus on specific conditions—ADHD, PTSD, insomnia, PMDD, etc.—aligns with this specialization trend.

Measurement-Based Care and Outcomes

Pressure is mounting for telehealth platforms to demonstrate clinical effectiveness, not just convenience:

• Systematic symptom tracking (e.g., PHQ-9 for depression, GAD-7 for anxiety)
• Functional outcome measures (work performance, relationship quality)
• Patient satisfaction beyond app ratings
• Long-term engagement and recovery rates

Platforms that can show superior outcomes will gain competitive advantages with insurers, employers, and patients.

The Weight Loss Wild Card

GLP-1 prescribing represents telehealth’s most dramatic recent expansion beyond traditional boundaries. As these medications become more affordable (with insurance coverage expanding and patents eventually expiring), weight management may become a standard offering for many mental health platforms.

This creates interesting opportunities: mental health and metabolic health interconnect significantly (depression and obesity often coexist; treating one can help the other). Platforms offering integrated mental health and weight management could provide holistic wellness services.

However, regulatory oversight will likely increase. The FDA’s 2025 warnings about compounded semaglutide signal authorities won’t allow unchecked expansion.

Choosing the Right Platform: A Decision Framework

With so many options, how do you choose?

If You Need ADHD Medication Management:

Best option: Talkiatry (if available in your state and insurance works) or Klarity Health for comprehensive ADHD care

Why: Most platforms won’t prescribe stimulants; you need specialized psychiatric services willing to navigate controlled substance regulations responsibly

What to avoid: General telehealth (Teladoc, PlushCare, etc.) categorically won’t help with ADHD medications; subscription services like Brightside explicitly exclude ADHD

If You Have Depression or Anxiety (Without Needing Controlled Medications):

Best options: Brightside, Klarity Health, or insurance-covered options through Talkiatry

Why: These conditions respond well to non-controlled medications (SSRIs, SNRIs) that all platforms readily prescribe; choose based on cost, insurance, and preference for subscription vs. pay-per-visit

Consider: Whether you want therapy included (Brightside’s higher-tier plans) or medication management only (more affordable)

If You’re Cost-Sensitive and Uninsured:

Best options: Klarity Health, PlushCare, or general telehealth platforms

Why: Pay-per-visit pricing often costs less annually than subscriptions if you don’t need weekly appointments; Klarity’s transparent pricing ($149 initial, $59 follow-ups) beats most alternatives

Avoid: Expensive subscription services or out-of-network psychiatric care (potentially $200–$400 per visit)

If You Have Good Insurance:

Best option: Talkiatry or ask your insurer about their telepsychiatry network

Why: Insurance dramatically reduces costs (often to copay levels of $25–$75); maximizes your benefits; provides full psychiatric care including controlled substances if needed

Consider: Whether you value the flexibility of out-of-network cash-pay services enough to justify higher costs

If You Need Specialized Care:

For conditions like PTSD, PMDD, insomnia, or binge eating disorder, look for platforms with specific expertise:

Klarity Health treats these often-underserved conditions with specialized protocols

Talkiatry offers comprehensive psychiatric care for complex cases

Brightside covers some (PTSD, OCD) but not others (ADHD, PMDD)

Generic platforms (Teladoc, etc.) often lack depth in these areas

What Makes Quality Telehealth Mental Health Care?

Not all online therapy and psychiatry delivers equal value. Quality telehealth should include:

Thorough Initial Assessment

Expect 45–60 minutes for a first psychiatric evaluation (for medication management). Brief 15–20 minute ‘evaluations’ raise red flags—legitimate diagnosis and treatment planning take time.

Quality providers ask about:

• Symptom history and severity
• Previous treatments and responses
• Medical history and current medications
• Substance use
• Family psychiatric history
• Social and occupational functioning
• Safety concerns

Evidence-Based Treatment

Providers should follow established clinical guidelines:

• Offering therapy (CBT, DBT, etc.) as first-line or alongside medication for many conditions
• Using FDA-approved medications for diagnosed conditions
• Avoiding off-label prescribing without clear rationale
• Regular monitoring and adjustment based on response

Continuity of Care

See the same provider consistently rather than rotating through different clinicians. Relationship continuity improves outcomes and allows your provider to notice subtle changes.

Clear Communication

Quality platforms provide:

• Transparent pricing before you commit
• Clear explanation of what they do and don’t treat
• Accessible customer support
• Secure messaging for non-urgent questions
• Coordination with other healthcare providers when needed

Appropriate Boundaries

Ethical telehealth includes knowing when not to treat remotely:

• Severe psychiatric emergencies (active suicidality, psychosis) need in-person crisis care
• Complex medication regimens may require specialist referral
• Certain conditions benefit from in-person assessment (e.g., movement disorders from medication)

Quality providers recognize these limits and help you access appropriate care rather than forcing everything into a telehealth model.

Klarity Health: Filling the Gap in Accessible, Specialized Mental Healthcare

As the telehealth mental health landscape has contracted—with some services shutting down and others restricting what they treat—a gap has emerged for patients seeking legitimate, accessible care for conditions many platforms avoid.

Klarity Health addresses this gap by offering:

Specialized Condition Focus

Klarity treats conditions that many competitors won’t or can’t manage effectively:

• ADHD (including controlled medication management when appropriate)
• PTSD with trauma-informed approaches
• Insomnia beyond basic sleep hygiene
• PMDD (premenstrual dysphoric disorder)
• Binge eating disorder
• Depression, anxiety, and related conditions

This specialization means providers have deep expertise rather than superficial familiarity across dozens of conditions.

Balanced Prescribing Philosophy

Unlike platforms that categorically refuse all controlled medications (Brightside, Teladoc) or those that faced scrutiny for over-prescribing (Done, early Cerebral), Klarity maintains a balanced approach:

• Controlled medications are prescribed when clinically appropriate and necessary
• But only after thorough evaluation
• With ongoing monitoring and follow-up
• Alongside therapy and lifestyle interventions when beneficial
• Following established medical guidelines

This evidence-based middle ground serves patients who need legitimate medication access but want responsible clinical oversight.

Transparent, Affordable Pricing

With clear costs ($149 initial evaluation, $59 follow-ups, $25 refills), patients know exactly what they’ll pay. This transparency, combined with acceptance of both insurance and cash payment, provides flexibility other platforms lack.

Annual costs for ongoing medication management often run 30–50% less than subscription competitors while maintaining quality care.

Fast Access Without Sacrificing Quality

Many patients turned to questionable telehealth services because traditional psychiatry has weeks or months of wait times. Klarity offers appointment availability typically within days while maintaining thorough clinical assessment.

This balance—speed and substance—addresses what patients actually need rather than forcing them to choose between quick-but-sketchy or slow-but-thorough.

Provider Continuity and Responsive Support

Learning from competitors’ weaknesses, Klarity emphasizes:

• Seeing the same provider for follow-ups when possible
• Responsive customer service for scheduling or technical issues
• Secure messaging for non-urgent clinical questions
• Care coordination when needed with other providers

Taking the Next Step: How to Get Started with Online Mental Health Care

If you’re ready to explore telehealth mental health services:

1. Clarify Your Needs

Identify:

• Primary symptoms or diagnosis you’re seeking help for
• Whether you’ve tried treatment before and what happened
• If you need therapy, medication, or both
• Your insurance situation
• Your budget for out-of-pocket care

2. Check Platform Availability and Policies

Before signing up:

• Verify the platform operates in your state
• Read their prescribing policies (especially if you need controlled medications)
• Understand their pricing structure
• Check insurance acceptance if relevant

3. Review Provider Credentials

Look for:

• Board-certified psychiatrists (MDs/DOs) for complex medication management
• Licensed psychiatric nurse practitioners (PMHNPs) for general medication management
• Licensed therapists (LCSWs, LMFTs, PhDs, PsyDs) for therapy
• Verify licensure in your state

4. Prepare for Your First Appointment

Gather:

• List of current medications and supplements
• Previous psychiatric or medical records if available
• Symptom timeline and severity
• Questions you want to ask
• Insurance information if using benefits

5. Evaluate the Experience

After your initial visits, assess:

• Did the provider listen and conduct a thorough evaluation?
• Do you feel the treatment plan makes sense?
• Is communication clear and timely?
• Are costs as expected?
• Do you feel your concerns are taken seriously?

If something feels off—rushed appointments, pressure to take medications you’re uncomfortable with, difficulty getting questions answered—trust your instincts and consider alternatives.

The Bottom Line: Telehealth Mental Health in 2026

The online mental health industry has matured dramatically from its pandemic-era ‘Wild West’ phase. The casualties—Done’s indictment, Ahead’s shutdown, Cerebral’s dramatic pivot—weren’t just business failures but necessary corrections in an industry that moved too fast without adequate safeguards.

What remains is a more sober, regulated, but still valuable ecosystem of services:

For straightforward depression or anxiety without need for controlled medications, numerous solid options exist across price points and service models.

For ADHD, PTSD, insomnia, and complex conditions, options have narrowed significantly. Specialized services like Klarity Health and insurance-based telepsychiatry like Talkiatry represent the primary legitimate telehealth pathways.

For general mental wellness and mild symptoms, lifestyle-focused platforms and app-based therapy can provide value.

The key is matching your specific needs with appropriate services—and recognizing that legitimate mental healthcare, even delivered remotely, requires time, expertise, and clinical judgment. Platforms promising instant solutions or making treatment seem effortless should raise skepticism.

As regulations continue evolving and the industry matures further, expect continued consolidation, tighter prescribing oversight, and growing integration with traditional healthcare systems. But the fundamental value proposition—accessible, affordable mental healthcare delivered where patients are—will endure.

If you’re struggling with mental health symptoms and traditional in-person care hasn’t worked due to cost, availability, or other barriers, quality telehealth services can provide real help. Do your research, choose providers with appropriate credentials and policies, and advocate for yourself if something doesn’t feel right.

Your mental health matters, and you deserve care that’s both accessible and excellent.

Ready to Get Started?

Klarity Health offers specialized mental health care for ADHD, PTSD, anxiety, depression, insomnia, PMDD, and more—with transparent pricing, fast appointments, and both insurance and cash payment options.

Learn more about how Klarity can help with your specific condition and schedule an initial evaluation today.

Citations & Research Currency Statement

Verified as of: January 4, 2026

All provider operating statuses, prescribing policies, and pricing verified through official websites and recent news coverage. Regulatory information confirmed via federal press releases and industry analysis dated 2024-2025.

Key References:

1. AP News – ‘Top executives of California telehealth company indicted in Adderall distribution scheme’ (June 14, 2024) – Federal prosecution of Done Global executives for controlled substance misprescribing (apnews.com)

2. TIME Magazine – ‘Why Online Therapy Startups Like Cerebral and Done Are Falling Short’ (November 1, 2022)

Source:

• https://www.techtarget.com/virtualhealthcare/news/366615298/Pushing-ADHD-telehealth-prescriptions-costs-Cerebral-millions#:~:text=Cerebral%20provides%20telehealth%20consultations%20for,from%20tiered%20monthly%20subscription%20plans
• https://finvsfin.com/hims-anxiety-reviews/#:~:text=Out%20of%20pocket%2C%20Hims%20will,99%20for%20each%20counseling%20session
• https://apnews.com/article/498cb907623565ee680b33b1367efb84#:~:text=Top%20executives%20of%20the%20California,executives%20of%20defrauding%20taxpayers%2C%20exacerbating
• https://time.com/6225361/telehealth-startups-cerebral-done-ahead/#:~:text=Halcyon%20Health%20and%20ADHD,Ahead%20shut%20down%20this%20year
• https://www.techtarget.com/virtualhealthcare/news/366615298/Pushing-ADHD-telehealth-prescriptions-costs-Cerebral-millions#:~:text=Embattled%20telemental%20healthcare%20provider%20Cerebral,unauthorized%20distribution%20of%20controlled%20substances
• https://apnews.com/article/9c08db3481dcfd67c433fad1ae07d941#:~:text=The%20FDA%20has%20launched%20its,originals%2C%20which%20the%20FDA%20disputes
• https://www.teladochealth.com/info/prescription-policy#:~:text=pressure%20medication,well%20as%20Teladoc%20Health%20policy
• https://www.brightside.com/faqs/what-medications-do-we-prescribe/#:~:text=Note%3A%20Brightside%20does%20not%20prescribe,controlled%20substance%20in%20some%20states
• https://time.com/6225361/telehealth-startups-cerebral-done-ahead/#:~:text=substance%20prescriptions%20from%20Cerebral%20and,substance%20medications
• https://h-o-m-e.org/does-cerebral-prescribe-xanax/#:~:text=Cerebral%20takes%20a%20conservative%20approach,such%20as%20Xanax%20or%20Ativan